Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Phase I/II Trial of Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Systemic Light-Chain Amyloidosis

NCT05451771 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT05451771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05451771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Phase I/II Trial of Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Systemic Light-Chain Amyloidosis
Lead sponsor
Columbia University
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
October 26, 2022
Completion date
September 30, 2027
Enrollment
53 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

al amyloidosis